news from utilzer

The latest updates on our medical diagnostic journey

October 2024

Meet us at MEDICA trade fair in Düsseldorf on 11-14 November 2024 where we’re looking forward to meeting potential distributors and partners. To pre-book your meeting with Utilizer Founder & CEO Sofia Bertling or Director of Marketing & Sales Gabriella von Flittner please get in touch prior to the event.

Karin Andersson Chairwoman of the Board Utilizer

January 2024

We are growing! Welcome Karin Andersson, we are proud to have you onboard! Karin joins as chairwoman of the board, bringing with her extensive strategic company experience based in Marketing & MedTech.

Shanila Mazid Director of Manufacturing Utilizer

November 2023

Welcome Shanila Mazid! Shanila joins our team as Director of Manufacturing, bringing with her extensive MedTech and scaled manufacturing experience. She will lead UTI-lizer’s journey towards scaled manufacturing.

Gino Jakobsson Chief Medical Officer Utilizer

October 2024

Please join us in extending a warm welcome to our newest team member; Gino Jakobsson a medical doctor with 5 years of experience as a healthcare professional including business development in the hospital setting and has an entrepreneurial background. He will join the team as Medical Affairs Liaison and have an important role in the journey ahead.

September 2023

We are exhibiting at Linus Dagarna together with EMM Life Science AB Växjö, 19-21 September 2023.

May 2023

We closed our first investment round and raised 7M SEK! The investors include ALMI Invest, together with life science angel investors and the Propel Capital. More information can be found in our press releases available in English and Swedish.

September 2023

We presented results of our clinical performance study at Karolinska University Hospital at ECCMID (European Society of Clinical Microbiology and Infectious Diseases) 2023.

September 2022

22 new companies of Sting are announced in Dagens Industri and Utilizer is one of them!

June 2022

We got support from Vinnova! Our preparatory project for international proposal is accepted. We will be setting a multi-center clinical trial for our tests at the point-of-care.